Terms ending in 2039
Every in-force patent on Fondation Imagine's record whose computed term ends in 2039, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 12,257,232 | Methods and Pharmaceutical Compositions for the Treatment of FGFR3-RELATED Chondrodysplasias Inserm (Institut National de la Sante et de la Recherche Medicale), Universite de Paris, Fondation Imagine, Assistance Publique-Hopitaux de Paris (Aphp) and Universidad de Granada In force · High confidence | Inserm (Institut National de la Sante et de la Recherche Medicale), Universite de Paris, Fondation Imagine, Assistance Publique-Hopitaux de Paris (Aphp) and Universidad de Granada | In force | High confidence | |
| US 11,473,145 | Methods for Determining Whether a Patient Suffering from Rhabdomyolysis Achieves a Response with a TLR9 Antagonist In force · Medium confidence | Université Paris Cité | In force | Medium confidence | |
| US 12,778,952 | Infigratinib for Treatment of FGFR3-RELATED Skeletal Diseases During Pregnancy In force · High confidence | Assistance Publique-Hôpitaux de Paris (Aphp) | In force | High confidence |
3 of 3 patents shown. Soonest term end first, then patent number.
2 of these are in force and held by Fondation Imagine.
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.